falsefalse

Howard L. Kaufman, MD - Episode 2

ImmunoScore: Predictive and Prognostic?

EP. 1: Society for Immunotherapy in Cancer
Now Viewing
EP. 2: ImmunoScore: Predictive and Prognostic?
EP. 3: Advances in Immuno-Oncology
EP. 4: Emerging Agents and Approaches in Immunotherapy
EP. 5: Patient Selection for Immunotherapies
EP. 6: Identifying and Managing Toxicities of Immunotherapy
EP. 7: Biomarkers and Immunotherapy
EP. 8: Phase I Immunotherapy Trials
EP. 9: Clinical Trial Design for Immunotherapy
EP. 10: History and Evolution of Immuno-oncology

Related Content:

Howard L. Kaufman, MDImmuno-OncologyOncology Nursing NewsSupportive Care
RP1 Yields Responses in Deep/Visceral Lesions and Across Injected/Non-Injected Lesions in Advanced PD-1–Refractory Melanoma
Exploratory Analysis From CALLA Study Highlights Potential Utility of ctDNA in Locally Advanced Cervical Cancer
First-Line Nivolumab Plus Ipilimumab Does Not Boost OS in Cisplatin-Ineligible Unresectable Urothelial Carcinoma
x